Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "ORPHAN DRUG|Designated/Withdrawn" in comments (approximate match)

Showing 411 - 420 of 623 results

First page
Previous page
Next page
Next page

BRENTUXIMAB

C67ORA155P

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT03057795: Phase 2 Interventional Active, not recruiting Classic Hodgkin Lymphoma

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03057795

Class:

PROTEIN

N-SULFOGLUCOSAMINE SULFOHYDROLASE

X0MD128U01

Subunit 1 (482) Similarity Search

Sequence Search

Subunit 1 (482) Similarity Search

Status:

Investigational

Source:

NCT02350816: Phase 2 Interventional Terminated Sanfilippo Syndrome

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02350816

Class:

PROTEIN

OZANEZUMAB

123I05210W

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT01753076: Phase 2 Interventional Completed Amyotrophic Lateral Sclerosis

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01753076

Class:

PROTEIN

MDX-1303

7D0R3114J3

Subunit 1 (453) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (453) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT01265745: Phase 1 Interventional Completed Anthrax

(2010)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01265745

Class:

PROTEIN

DEPATUXIZUMAB

W984C353CG

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT02213289: Phase 2 Interventional Completed Adenocarcinoma

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02213289

Class:

PROTEIN

LINTUZUMAB

V00Y10W60W

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT00528333: Phase 2 Interventional Completed Acute Myeloid Leukemia

(2007)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00528333

Class:

PROTEIN

SIPLIZUMAB

KUW1QG1ZM3

Sequence Search

Status:

Investigational

Source:

NCT04311632: Phase 2 Interventional Completed Kidney Transplantation

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04311632

Class:

PROTEIN

SIMTUZUMAB

11Z5AIU653

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT02466516: Phase 2 Interventional Completed Non-Alcoholic Steatohepatitis (NASH)

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02466516

Class:

PROTEIN

SECRETORY LEUKOCYTE PROTEASE INHIBITOR

909E17P4ZW

Subunit 1 (107) Similarity Search

Sequence Search

Subunit 1 (107) Similarity Search

Status:

Investigational

Source:

NCT00005569: Phase 1 Interventional Completed Healthy

(2000)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00005569

Class:

PROTEIN

GAVILIMOMAB

TCR92293RC

Sequence Search

Status:

Investigational

Source:

NCT00035880: Phase 2/Phase 3 Interventional Completed Graft Vs Host Disease

(1999)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00035880

Class:

PROTEIN

Protein

Protein

N-SULFOGLUCOSAMINE SULFOHYDROLASE

Protein

Protein

Protein

Protein

Protein

Protein

Protein

SECRETORY LEUKOCYTE PROTEASE INHIBITOR

Protein

Showing 411 - 420 of 623 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1